ZYBT
Zhengye Biotechnology Holding Limited Ordinary Shares
NASDAQ: ZYBT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.92
+4.70% today
Updated 2026-04-28
Market cap
$43.72M
P/E ratio
—
P/S ratio
0.28x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$1 – $14
Volume
0.3M
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 3
Last 3 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.9%
Last 1 reports
Positive reaction rate
0%
0 of 1 quarters
Largest single-day move
-4.9%
2025-12-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-12 | $-0.46 | — | $2.03 | $1.93 | -4.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-09-30 | $0.00 | $-0.46 | — | — | — |
| 2025-06-30 | $0.00 | $0.05 | — | — | — |
| 2024-09-30 | $0.00 | $0.20 | — | — | — |
Frequently asked questions
Has Zhengye Biotechnology Holding Limited Ordinary Shares beaten earnings estimates?
Zhengye Biotechnology Holding Limited Ordinary Shares has beaten Wall Street EPS estimates in 2 of its last 3 quarterly reports.
How does ZYBT stock react to earnings?
ZYBT stock has moved an average of -4.9% in the trading day following earnings over its last 1 reports, with positive reactions in 0% of those quarters.